Physician
Western New York Medical Practice P.C.
Western New York Medical Practice P.C. was paid $13.41M by Medicaid between Jan 2018 and Dec 2024, across 127 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoWESTERN NEW YORK MEDICAL PRACTICE P.C.
ROCHESTER, NY 14621
ROCHESTER, NY 14621
33aNPI1063790608assigned 08/01/2011
33bProvider typePediatrics Physician
28Total paid$13.41M
24GClaims213,682
24DCodes billed127
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#14 of 1,983
Median peer was paid$17K
This provider vs. median790×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TINCH, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,182 | $460K | |
| 2019 | 15,679 | $846K | |
| 2020 | 27,542 | $1.58M | |
| 2021 | 41,079 | $2.71M | |
| 2022 | 43,183 | $2.88M | |
| 2023 | 51,813 | $3.35M | |
| 2024incomplete | 26,204 | $1.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 98,138 | 94,116 | $6.32M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 37,936 | 36,362 | $3.79M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.1% | 9,277 | 9,260 | $823K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.9% | 4,027 | 4,015 | $526K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.1% | 748 | 745 | $146K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,214 | 1,214 | $124K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,369 | 3,157 | $123K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,071 | 1,069 | $109K |
| 95117 | <1% | 10,241 | 4,362 | $89K | |
| 20610 | <1% | 1,493 | 1,457 | $82K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 685 | 684 | $78K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 4,242 | 3,852 | $74K |
115 more codes
| 0002A | <1% | 1,750 | $69K | |
| 73630 | <1% | 2,453 | $69K | |
| 20611 | <1% | 839 | $68K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 470 | $63K |
| 0001A | <1% | 1,705 | $62K | |
| V2020 | Frames, purchases | <1% | 1,398 | $61K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 663 | $57K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 473 | $45K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 40 | $45K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 191 | $40K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 241 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 644 | $32K |
| 72110 | <1% | 716 | $28K | |
| 92557 | <1% | 874 | $27K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 409 | $25K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 212 | $23K |
| 81000 | <1% | 6,406 | $23K | |
| 99442 | <1% | 395 | $21K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 318 | $20K |
| 99205 | Prolong outpt/office vis | <1% | 94 | $18K |
| 92567 | <1% | 1,112 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,537 | $14K |
| 51798 | <1% | 1,260 | $13K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 192 | $13K |
| 73564 | <1% | 321 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,058 | $12K |
| 73562 | <1% | 343 | $11K | |
| 90686 | <1% | 1,652 | $10K | |
| 73030 | <1% | 379 | $10K | |
| 93299 | <1% | 54 | $9K | |
| 73110 | <1% | 269 | $9K | |
| 92550 | <1% | 433 | $7K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 39 | $7K |
| 99152 | <1% | 366 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 105 | $7K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 52 | $7K |
| 64483 | <1% | 48 | $6K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 120 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 228 | $6K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 38 | $5K |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 702 | $5K |
| 73610 | <1% | 178 | $5K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 619 | $5K |
| 93298 | <1% | 229 | $5K | |
| 11721 | <1% | 177 | $4K | |
| 31231 | <1% | 25 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 37 | $3K |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 17 | $3K |
| 99460 | <1% | 37 | $3K | |
| 73140 | <1% | 104 | $3K | |
| 52000 | <1% | 17 | $3K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 25 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 522 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 799 | $3K |
| 92015 | Determination of refractive state | <1% | 208 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 107 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 60 | $3K |
| 11900 | <1% | 52 | $2K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 37 | $2K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 59 | $2K |
| 99406 | <1% | 132 | $2K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 57 | $2K |
| 81002 | <1% | 596 | $2K | |
| 73130 | <1% | 53 | $2K | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 36 | $2K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 483 | $2K |
| 92551 | <1% | 188 | $2K | |
| 0071A | <1% | 35 | $1K | |
| 93000 | <1% | 137 | $1K | |
| 69210 | <1% | 42 | $1K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 34 | $1K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 13 | $1K |
| G0008 | Administration of influenza virus vaccine | <1% | 167 | $935.91 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 13 | $889.22 |
| 97803 | <1% | 16 | $862.40 | |
| 82947 | <1% | 227 | $837.91 | |
| 80305 | <1% | 85 | $834.86 | |
| 0072A | <1% | 19 | $806.30 | |
| 64484 | <1% | 17 | $759.42 | |
| 95251 | <1% | 43 | $750.67 | |
| 99051 | <1% | 105 | $736.45 | |
| 90682 | <1% | 12 | $716.18 | |
| 99441 | <1% | 32 | $706.52 | |
| 72170 | <1% | 31 | $697.42 | |
| 92588 | <1% | 12 | $641.05 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 64 | $593.50 |
| 90656 | <1% | 45 | $494.13 | |
| 96127 | <1% | 107 | $459.51 | |
| 99173 | <1% | 601 | $455.96 | |
| 90688 | <1% | 25 | $448.17 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,877 | $412.01 |
| 92250 | <1% | 12 | $403.18 | |
| 0012A | <1% | 19 | $399.74 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 25 | $352.59 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 40 | $340.69 |
| S0580 | Polycarbonate lens (list this code in addition to the basic code for the lens) | <1% | 14 | $280.00 |
| 77003 | <1% | 14 | $278.19 | |
| 90670 | <1% | 120 | $254.09 | |
| 90619 | <1% | 15 | $193.31 | |
| 83655 | <1% | 14 | $164.69 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14 | $154.97 |
| 81025 | <1% | 40 | $152.31 | |
| 99177 | <1% | 99 | $123.78 | |
| 85018 | <1% | 27 | $60.13 | |
| 82962 | <1% | 14 | $42.49 | |
| 94760 | <1% | 231 | $36.99 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $13.20 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 28 | $0.24 |
| 99024 | 0% | 76 | $0.00 | |
| 90697 | 0% | 42 | $0.00 | |
| 90651 | 0% | 39 | $0.00 | |
| 90680 | 0% | 41 | $0.00 | |
| 90734 | 0% | 36 | $0.00 | |
| 90633 | 0% | 24 | $0.00 | |
| 90461 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTINCH, PAULA (SVP- FINANCE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.